Tuesday, June 3, 2014
UFC’s Ali Bagautinov Failed Drug Test In 2012
It has recently come to light that UFC flyweight title challenger and Sambo champion Ali Bagautinov, was banned by the International Sambo Federation (FIAS) back in 2012 for a positive drug test.
The positive test was for Methylhexaneamine, commonly known as 1,3-dimethylamylamine or DMAA. DMAA is an inhaled nasal decongestant pharmaceutical drug that was produced by Lilly, whilst also a indirect sympathomimetic drug and stimulant.
The positive test landed Bagautinov a two-year ban from 9th November – 8th November 2014. Forfeiture of any medals, points and prizes and also any financial gain by being part of the FIAS.
However, this was in late 2012 but it seems this suspension is still in place. Bagautinov has a title fight coming up in the UFC 173 main event. But Dana White, UFC’s president, doesn’t seem interested that he is banned in another sport. Dana White was asked and he declined to comment, stating only that it “wasn’t important.”
Methylhexaneamine has hit the headlines before when Major League Baseball and the World Anti-Doping Agency, banned Jays prospect Marcus Stroman for 50 games. Methylhexaneamine is one of 56 stimulants on the banned list by the MLB.
While it’s chemically related to amphetamines, it’s only slightly more powerful than a cup of coffee, according to Greg Wells, a kinesiology professor at the University of Toronto who has educated Olympic athletes on doping rules.
“It’s a short-acting stimulant, but it’s not something that we need to hang this guy up for anything like that,” Wells said. “It’s not a big deal.”
Source:
.jpg)
